Table 5

Characteristics of participants with PDPS with faster and slower disappearance of symptoms

CharacteristicsFast disappearance (≤10 min)Slow disappearance (>10 min)P valueES
Participants, n (%)25 (57)19 (43)n/an/a
Female, n (%)16 (64)14 (74)0.534Phi=0.10
Age (years)22.0 (IQR 6.0)20.0 (IQR 5.0)0.229r=0.18
BMI (kg/m2)24.1 (IQR 4.1)22.4 (IQR 5.0)0.112r=0.24
Sport participation (h/week)3.6 (SD±2.0, R 7.0)2.3 (SD±1.9, R 6.0)0.036d=0.66
Tegner Score (0–10)4.0 (IQR 3.0)3.0 IQR (2.0)0.197r=0.19
VAS-W (0–10)5.0 (IQR 3.0)6.0 (IQR 2.0)0.379r=0.13
Bilateral PFP, n (%)17 (68)17 (90)0.148Phi=0.25
Symptom duration (months)36.0 (IQR 54.5)42.0 (IQR 60.0)0.406r=0.13
AKPS (0–100)74.0 (IQR 16.0)67.0 (IQR 12.0)0.005r=0.43
TSK (17–68)32.0 (IQR 8.0)33.0 (IQR 14.0)0.374r=0.13
VAS-W sitting (0–10)5.0 (IQR 4.0)6.0 (IQR 2.0)0.156r=0.21
  • Data are presented as numbers (percentages), mean (±SD and range (R)) or median (IQR 25%–75%).

  • AKPS, Anterior Knee Pain Scale; BMI, body mass index; ES, effect size; h/week, hours per week; n, number; n/a, not applicable; PFP, patellofemoral pain; TSK, Tampa Scale for Kinesiophobia; VAS-W, Visual Analogue Scale for Worst pain.